Literature DB >> 15287027

Loss of chromosome arm 18q with tumor progression in head and neck squamous cancer.

Satoru Takebayashi1, Arthur Hickson, Tetsuya Ogawa, Kwang-Yoon Jung, Hiroyuki Mineta, Yo Ueda, Reidar Grénman, Susan G Fisher, Thomas E Carey.   

Abstract

Loss of 18q was analyzed in 21 sets of head and neck squamous cell carcinoma (HNSCC) cell lines derived from primary and secondary tumors in the same patients. Only 3 of the 21 cell line pairs had no loss of 18q. In the remaining 18 sets, loss of heterozygosity (LOH) affecting 18q was found in either the primary or the secondary lines or both. In every case but one, the same chromosome was affected in both the primary and secondary cell lines. In 8 sets, the 18q loss occurred in the primary tumor and remained stable through the subsequent tumor progression. The primary and secondary lines differed in 18q loss in 10 of 18 (56%) cases with 18q LOH. In 3 of the 10 pairs that differed, 18q LOH was found in only the primary line, indicating that the loss developed after the metastatic or recurrent tumor population had diverged from the primary tumor population. In the other 7 pairs, 18q LOH developed or progressed with tumor recurrence or metastasis. Of these, 3 of 7 had 18q LOH in only the secondary lines, and 4 of 7 had 18q LOH in both the primary and secondary lines, but the extent of LOH was greater in the secondary lines than in the primary lines, indicating that additional rearrangements of the same chromosome occurred with progression. These cases showed that interstitial loss often progresses to consolidated loss in vivo. However, in vitro, the cell lines from the primary tumors with interstitial loss maintain those chromosomes over long-term culture. LOH on 18q in cell lines from previously untreated primary tumors was significantly associated with advanced tumor stage (P=0.0242) and decreased survival (P=0.0453). The findings are consistent with the concept that 18q LOH is an event associated with tumor progression and suggest that inactivation and loss of one or more genes on 18q contributes to aggressive tumor behavior. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15287027     DOI: 10.1002/gcc.20066

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  19 in total

1.  Epigenetic inactivation of galanin receptor 1 in head and neck cancer.

Authors:  Kiyoshi Misawa; Yo Ueda; Takeharu Kanazawa; Yuki Misawa; Ilwhan Jang; John Chadwick Brenner; Tetsuya Ogawa; Satoru Takebayashi; Reidar A Grenman; James G Herman; Hiroyuki Mineta; Thomas E Carey
Journal:  Clin Cancer Res       Date:  2008-12-01       Impact factor: 12.531

Review 2.  Paradoxical roles of TGF-β signaling in suppressing and promoting squamous cell carcinoma.

Authors:  Fanglong Wu; Kelsey J Weigel; Hongmei Zhou; Xiao-Jing Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2018-01-01       Impact factor: 3.848

Review 3.  Lessons learned from SMAD4 loss in squamous cell carcinomas.

Authors:  Ariel L Hernandez; Christian D Young; Jing H Wang; Xiao-Jing Wang
Journal:  Mol Carcinog       Date:  2019-05-29       Impact factor: 4.784

4.  Clinicopathological and prognostic implications of genetic alterations in oral cancers.

Authors:  Swapnali M Pathare; Moritz Gerstung; Niko Beerenwinkel; Alejandro A Schäffer; Sadhana Kannan; Prathamesh Pai; K Alok Pathak; Anita M Borges; Manoj B Mahimkar
Journal:  Oncol Lett       Date:  2011-05       Impact factor: 2.967

5.  Galanin receptor subtype 2 suppresses cell proliferation and induces apoptosis in p53 mutant head and neck cancer cells.

Authors:  Takeharu Kanazawa; Pavan K Kommareddi; Toshihide Iwashita; Bhavna Kumar; Kiyoshi Misawa; Yuki Misawa; Ilwhan Jang; Thankam S Nair; Yukiko Iino; Thomas E Carey
Journal:  Clin Cancer Res       Date:  2009-03-10       Impact factor: 12.531

6.  [Constitutive expression of the potential stem cell marker CD44 in permanent HNSCC cell lines].

Authors:  R Pries; N Wittkopf; K Hasselbacher; B Wollenberg
Journal:  HNO       Date:  2008-04       Impact factor: 1.284

Review 7.  [Epigenetic aspects in carcinomas of the head and neck].

Authors:  P Schmezer; C Plass
Journal:  HNO       Date:  2008-06       Impact factor: 1.284

Review 8.  Chromosomal imbalances in oral squamous cell carcinoma: examination of 31 cell lines and review of the literature.

Authors:  Christa Lese Martin; Shalini C Reshmi; Thomas Ried; William Gottberg; John W Wilson; Jaya K Reddy; Poornima Khanna; Jonas T Johnson; Eugene N Myers; Susanne M Gollin
Journal:  Oral Oncol       Date:  2007-08-02       Impact factor: 5.337

Review 9.  DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: a review.

Authors:  Yu Chen; Chu Chen
Journal:  Head Neck       Date:  2008-10       Impact factor: 3.147

10.  Array-comparative genomic hybridization reveals loss of SOCS6 is associated with poor prognosis in primary lung squamous cell carcinoma.

Authors:  Krishna B Sriram; Jill E Larsen; Santiyagu M Savarimuthu Francis; Casey M Wright; Belinda E Clarke; Edwina E Duhig; Kevin M Brown; Nicholas K Hayward; Ian A Yang; Rayleen V Bowman; Kwun M Fong
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.